Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 8, 2019
Humoral response to Clostridium difficile in inflammatory bowel disease, including correlation with immunomodulatory treatmentGunnel Henriksson, Johan Bredberg, Marlene Wullt, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 19, 2010
Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivoDevipriya Subramaniyam, Chad Steele, Thomas Köhnlein, et al.
Lakartidningen|August 14, 2024
[Health-related quality of life for patients with inflammatory bowel disease requires more than anti-inflammatory treatment]Stefan Lindgren, Sven Almer, Daniel Bergemalm, et al.
Plos One|December 10, 2015
A Single-Cell Gene-Expression Profile Reveals Inter-Cellular Heterogeneity within Human Monocyte SubsetsSusanne T Gren, Thomas B Rasmussen, Sabina Janciauskiene, et al.
Scandinavian Journal of Gastroenterology|August 9, 2021
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017Jonas F Ludvigsson, Johanna Holmgren, Olof Grip, et al.
Journal of Leukocyte Biology|November 12, 2013
CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's diseaseSusanne Thiesen, Sabina Janciauskiene, Heli Uronen-Hansson, et al.
Journal of Leukocyte Biology|May 19, 2016
The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytesSusanne Thiesen Gren, Sabina Janciauskiene, Salipalli Sandeep, et al.
Inflammatory Bowel Diseases|July 1, 2022
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort StudyJohanna Holmgren, Anna Fröborg, Isabella Visuri, et al.
Therapeutic Advances in Gastroenterology|October 23, 2018
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel diseaseViktoria Bergqvist, Mohammad Kadivar, Daniel Molin, et al.
Scandinavian Journal of Gastroenterology|October 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)Sara Rundquist, Carl Eriksson, Linda Nilsson, et al.
Pageof 5